Novel Anti-CD19 Universal CAR-T Cells for r/r CD19+ B-ALL
NCT05639179
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
30
Enrollment
OTHER
Sponsor class
Conditions
B-cell Acute Lymphoblastic Leukemia
B-ALL
Interventions
BIOLOGICAL:
UCAR-T Cells
Sponsor
920th Hospital of Joint Logistics Support Force of People's Liberation Army of China